Anti-Viral Therapies Market 2027 By Type, Drug Class, Application | The Insight Partners

Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Generic Drugs, Branded Drugs); Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug Classes); Application (HIV, Hepatitis, Herpes, Influenza, Other Applications)

Report Code: TIPRE00012650 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid

MARKET INTRODUCTION

Antiviral therapies are used to control viral diseases such as HIV, hepatitis, influenza, and others. There are several antiviral agents used to overcome the impact of viral infections and diseases. Also, combinations of agents are increasingly being used to delay or prevent resistance, to achieve synergistic inhibition of viruses, and to decrease dosages of toxic drugs. Moreover, the new antiviral drug development is in progress, with active drug discovery programs for coronavirus.

MARKET DYNAMICS

The anti-viral therapies market is driving due to the rise in health care expenditure, increasing viral infections, and introduction of new drugs with improved efficacy. However, high cost of anti-viral therapies is expected to hamper the growth of the global anti-viral therapies market. Moreover, stronger pipeline of anti-viral drugs is anticipated to drive demand for anti-viral therapies in the forecast period. 

MARKET SCOPE

The "Anti-Viral Therapies Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-viral therapies market with detailed market segmentation by type, dug class, and application. The anti-viral therapies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-viral therapies market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anti-viral therapies market is segmented on the basis of type, dug class, and application. Based on type, the market is segmented as generic drugs and branded drugs. On the basis of dug class, the market is categorized as DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors and other drug classes. Based on application, the market is categorized as HIV, hepatitis, herpes, influenza, and other applications.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-viral therapies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-viral therapies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-viral therapies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-viral therapies market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the anti-viral therapies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-viral therapies market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-viral therapies in the global market. Below mentioned is the list of few companies engaged in the anti-viral therapies market.

The report also includes the profiles of key players in anti-viral therapies market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck and Co., Inc.
  •  Dr. Reddy’s Laboratories Ltd.
  •  Cipla Inc.
  •  Bristol-Myers Squibb Company
  •  Johnson and Johnson Services, Inc.
  •  Aurobindo Pharma
  •  AbbVie Inc.
  •  GlaxoSmithKline plc.
  •  F. Hoffmann-La Roche Ltd
  •  Gilead Sciences, Inc.

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.



Get more information on this report :

1.        INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Anti-Viral Therapies Market - By Type

                         1.3.2   Anti-Viral Therapies Market - By Drug Class

                         1.3.3   Anti-Viral Therapies Market - By Application

                         1.3.4   Anti-Viral Therapies Market - By Region

                                     1.3.4.1   By Country

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        ANTI-VIRAL THERAPIES MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        North America - Pest Analysis

                         4.2.2        Europe - Pest Analysis

                         4.2.3        Asia-Pacific - Pest Analysis

                         4.2.4        Middle East and Africa - Pest Analysis

                         4.2.5        South and Central America - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        ANTI-VIRAL THERAPIES MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.        ANTI-VIRAL THERAPIES MARKET - GLOBAL MARKET ANALYSIS

            6.1.       ANTI-VIRAL THERAPIES - GLOBAL MARKET OVERVIEW

            6.2.       ANTI-VIRAL THERAPIES - GLOBAL MARKET AND FORECAST TO 2027

            6.3.       MARKET POSITIONING/MARKET SHARE

7.        ANTI-VIRAL THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 – TYPE

            7.1.       OVERVIEW

            7.2.       TYPE MARKET FORECASTS AND ANALYSIS

            7.3.       GENERIC DRUGS

                          7.3.1.         Overview

                          7.3.2.         Generic Drugs Market Forecast and Analysis

            7.4.       BRANDED DRUGS

                          7.4.1.         Overview

                          7.4.2.         Branded Drugs Market Forecast and Analysis

8.        ANTI-VIRAL THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 – DRUG CLASS

            8.1.       OVERVIEW

            8.2.       DRUG CLASS MARKET FORECASTS AND ANALYSIS

            8.3.       DNA POLYMERASE INHIBITORS

                          8.3.1.         Overview

                          8.3.2.         DNA Polymerase Inhibitors Market Forecast and Analysis

            8.4.       REVERSE TRANSCRIPTASE INHIBITORS

                          8.4.1.         Overview

                          8.4.2.         Reverse Transcriptase Inhibitors Market Forecast and Analysis

            8.5.       PROTEASE INHIBITORS

                          8.5.1.         Overview

                          8.5.2.         Protease Inhibitors Market Forecast and Analysis

            8.6.       NEURAMINIDASE INHIBITORS

                          8.6.1.         Overview

                          8.6.2.         Neuraminidase Inhibitors Market Forecast and Analysis

            8.7.       OTHER DRUG CLASSES

                          8.7.1.         Overview

                          8.7.2.         Other Drug Classes Market Forecast and Analysis

9.        ANTI-VIRAL THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 – APPLICATION

            9.1.       OVERVIEW

            9.2.       APPLICATION MARKET FORECASTS AND ANALYSIS

            9.3.       HIV

                          9.3.1.         Overview

                          9.3.2.         HIV Market Forecast and Analysis

            9.4.       HEPATITIS

                          9.4.1.         Overview

                          9.4.2.         Hepatitis Market Forecast and Analysis

            9.5.       HERPES

                          9.5.1.         Overview

                          9.5.2.         Herpes Market Forecast and Analysis

            9.6.       INFLUENZA

                          9.6.1.         Overview

                          9.6.2.         Influenza Market Forecast and Analysis

            9.7.       OTHER APPLICATIONS

                          9.7.1.         Overview

                          9.7.2.         Other Applications Market Forecast and Analysis

10.        ANTI-VIRAL THERAPIES MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS

               10.1.       NORTH AMERICA

                                10.1.1      North America Anti-Viral Therapies Market Overview

                                10.1.2      North America Anti-Viral Therapies Market Forecasts and Analysis

                                10.1.3      North America Anti-Viral Therapies Market Forecasts and Analysis - By Type

                                10.1.4      North America Anti-Viral Therapies Market Forecasts and Analysis - By Drug Class

                                10.1.5      North America Anti-Viral Therapies Market Forecasts and Analysis - By Application

                                10.1.6      North America Anti-Viral Therapies Market Forecasts and Analysis - By Countries

                                                10.1.6.1     United States Anti-Viral Therapies Market

                                                                       10.1.6.1.1      United States Anti-Viral Therapies Market by Type

                                                                       10.1.6.1.2      United States Anti-Viral Therapies Market by Drug Class

                                                                       10.1.6.1.3      United States Anti-Viral Therapies Market by Application

                                                10.1.6.2     Canada Anti-Viral Therapies Market

                                                                       10.1.6.2.1      Canada Anti-Viral Therapies Market by Type

                                                                       10.1.6.2.2      Canada Anti-Viral Therapies Market by Drug Class

                                                                       10.1.6.2.3      Canada Anti-Viral Therapies Market by Application

                                                10.1.6.3     Mexico Anti-Viral Therapies Market

                                                                       10.1.6.3.1      Mexico Anti-Viral Therapies Market by Type

                                                                       10.1.6.3.2      Mexico Anti-Viral Therapies Market by Drug Class

                                                                       10.1.6.3.3      Mexico Anti-Viral Therapies Market by Application

               10.2.       EUROPE

                                10.2.1      Europe Anti-Viral Therapies Market Overview

                                10.2.2      Europe Anti-Viral Therapies Market Forecasts and Analysis

                                10.2.3      Europe Anti-Viral Therapies Market Forecasts and Analysis - By Type

                                10.2.4      Europe Anti-Viral Therapies Market Forecasts and Analysis - By Drug Class

                                10.2.5      Europe Anti-Viral Therapies Market Forecasts and Analysis - By Application

                                10.2.6      Europe Anti-Viral Therapies Market Forecasts and Analysis - By Countries

                                                10.2.6.1     Germany Anti-Viral Therapies Market

                                                                       10.2.6.1.1      Germany Anti-Viral Therapies Market by Type

                                                                       10.2.6.1.2      Germany Anti-Viral Therapies Market by Drug Class

                                                                       10.2.6.1.3      Germany Anti-Viral Therapies Market by Application

                                                10.2.6.2     France Anti-Viral Therapies Market

                                                                       10.2.6.2.1      France Anti-Viral Therapies Market by Type

                                                                       10.2.6.2.2      France Anti-Viral Therapies Market by Drug Class

                                                                       10.2.6.2.3      France Anti-Viral Therapies Market by Application

                                                10.2.6.3     Italy Anti-Viral Therapies Market

                                                                       10.2.6.3.1      Italy Anti-Viral Therapies Market by Type

                                                                       10.2.6.3.2      Italy Anti-Viral Therapies Market by Drug Class

                                                                       10.2.6.3.3      Italy Anti-Viral Therapies Market by Application

                                                10.2.6.4     Spain Anti-Viral Therapies Market

                                                                       10.2.6.4.1      Spain Anti-Viral Therapies Market by Type

                                                                       10.2.6.4.2      Spain Anti-Viral Therapies Market by Drug Class

                                                                       10.2.6.4.3      Spain Anti-Viral Therapies Market by Application

                                                10.2.6.5     United Kingdom Anti-Viral Therapies Market

                                                                       10.2.6.5.1      United Kingdom Anti-Viral Therapies Market by Type

                                                                       10.2.6.5.2      United Kingdom Anti-Viral Therapies Market by Drug Class

                                                                       10.2.6.5.3      United Kingdom Anti-Viral Therapies Market by Application

               10.3.       ASIA-PACIFIC

                                10.3.1      Asia-Pacific Anti-Viral Therapies Market Overview

                                10.3.2      Asia-Pacific Anti-Viral Therapies Market Forecasts and Analysis

                                10.3.3      Asia-Pacific Anti-Viral Therapies Market Forecasts and Analysis - By Type

                                10.3.4      Asia-Pacific Anti-Viral Therapies Market Forecasts and Analysis - By Drug Class

                                10.3.5      Asia-Pacific Anti-Viral Therapies Market Forecasts and Analysis - By Application

                                10.3.6      Asia-Pacific Anti-Viral Therapies Market Forecasts and Analysis - By Countries

                                                10.3.6.1     Australia Anti-Viral Therapies Market

                                                                       10.3.6.1.1      Australia Anti-Viral Therapies Market by Type

                                                                       10.3.6.1.2      Australia Anti-Viral Therapies Market by Drug Class

                                                                       10.3.6.1.3      Australia Anti-Viral Therapies Market by Application

                                                10.3.6.2     China Anti-Viral Therapies Market

                                                                       10.3.6.2.1      China Anti-Viral Therapies Market by Type

                                                                       10.3.6.2.2      China Anti-Viral Therapies Market by Drug Class

                                                                       10.3.6.2.3      China Anti-Viral Therapies Market by Application

                                                10.3.6.3     India Anti-Viral Therapies Market

                                                                       10.3.6.3.1      India Anti-Viral Therapies Market by Type

                                                                       10.3.6.3.2      India Anti-Viral Therapies Market by Drug Class

                                                                       10.3.6.3.3      India Anti-Viral Therapies Market by Application

                                                10.3.6.4     Japan Anti-Viral Therapies Market

                                                                       10.3.6.4.1      Japan Anti-Viral Therapies Market by Type

                                                                       10.3.6.4.2      Japan Anti-Viral Therapies Market by Drug Class

                                                                       10.3.6.4.3      Japan Anti-Viral Therapies Market by Application

                                                10.3.6.5     South Korea Anti-Viral Therapies Market

                                                                       10.3.6.5.1      South Korea Anti-Viral Therapies Market by Type

                                                                       10.3.6.5.2      South Korea Anti-Viral Therapies Market by Drug Class

                                                                       10.3.6.5.3      South Korea Anti-Viral Therapies Market by Application

               10.4.       MIDDLE EAST AND AFRICA

                                10.4.1      Middle East and Africa Anti-Viral Therapies Market Overview

                                10.4.2      Middle East and Africa Anti-Viral Therapies Market Forecasts and Analysis

                                10.4.3      Middle East and Africa Anti-Viral Therapies Market Forecasts and Analysis - By Type

                                10.4.4      Middle East and Africa Anti-Viral Therapies Market Forecasts and Analysis - By Drug Class

                                10.4.5      Middle East and Africa Anti-Viral Therapies Market Forecasts and Analysis - By Application

                                10.4.6      Middle East and Africa Anti-Viral Therapies Market Forecasts and Analysis - By Countries

                                                10.4.6.1     South Africa Anti-Viral Therapies Market

                                                                       10.4.6.1.1      South Africa Anti-Viral Therapies Market by Type

                                                                       10.4.6.1.2      South Africa Anti-Viral Therapies Market by Drug Class

                                                                       10.4.6.1.3      South Africa Anti-Viral Therapies Market by Application

                                                10.4.6.2     Saudi Arabia Anti-Viral Therapies Market

                                                                       10.4.6.2.1      Saudi Arabia Anti-Viral Therapies Market by Type

                                                                       10.4.6.2.2      Saudi Arabia Anti-Viral Therapies Market by Drug Class

                                                                       10.4.6.2.3      Saudi Arabia Anti-Viral Therapies Market by Application

                                                10.4.6.3     U.A.E Anti-Viral Therapies Market

                                                                       10.4.6.3.1      U.A.E Anti-Viral Therapies Market by Type

                                                                       10.4.6.3.2      U.A.E Anti-Viral Therapies Market by Drug Class

                                                                       10.4.6.3.3      U.A.E Anti-Viral Therapies Market by Application

               10.5.       SOUTH AND CENTRAL AMERICA

                                10.5.1      South and Central America Anti-Viral Therapies Market Overview

                                10.5.2      South and Central America Anti-Viral Therapies Market Forecasts and Analysis

                                10.5.3      South and Central America Anti-Viral Therapies Market Forecasts and Analysis - By Type

                                10.5.4      South and Central America Anti-Viral Therapies Market Forecasts and Analysis - By Drug Class

                                10.5.5      South and Central America Anti-Viral Therapies Market Forecasts and Analysis - By Application

                                10.5.6      South and Central America Anti-Viral Therapies Market Forecasts and Analysis - By Countries

                                                10.5.6.1     Brazil Anti-Viral Therapies Market

                                                                       10.5.6.1.1      Brazil Anti-Viral Therapies Market by Type

                                                                       10.5.6.1.2      Brazil Anti-Viral Therapies Market by Drug Class

                                                                       10.5.6.1.3      Brazil Anti-Viral Therapies Market by Application

                                                10.5.6.2     Argentina Anti-Viral Therapies Market

                                                                       10.5.6.2.1      Argentina Anti-Viral Therapies Market by Type

                                                                       10.5.6.2.2      Argentina Anti-Viral Therapies Market by Drug Class

                                                                       10.5.6.2.3      Argentina Anti-Viral Therapies Market by Application

11.        IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI-VIRAL THERAPIES MARKET

               11.1        North America

               11.2        Europe

               11.3        Asia-Pacific

               11.4        Rest of the World

12.        INDUSTRY LANDSCAPE

               12.1.       MERGERS AND ACQUISITIONS

               12.2.       AGREEMENTS, COLLABORATIONS AND JOIN VENTURES

               12.3.       NEW PRODUCT LAUNCHES

               12.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13.        ANTI-VIRAL THERAPIES MARKET, KEY COMPANY PROFILES

               13.1.     MERCK AND CO., INC.

                              13.1.1.      Key Facts

                              13.1.2.      Business Description

                              13.1.3.      Products and Services

                              13.1.4.      Financial Overview

                              13.1.5.      SWOT Analysis

                              13.1.6.      Key Developments

               13.2.     DR. REDDY’S LABORATORIES LTD.

                              13.2.1.      Key Facts

                              13.2.2.      Business Description

                              13.2.3.      Products and Services

                              13.2.4.      Financial Overview

                              13.2.5.      SWOT Analysis

                              13.2.6.      Key Developments

               13.3.     CIPLA INC.

                              13.3.1.      Key Facts

                              13.3.2.      Business Description

                              13.3.3.      Products and Services

                              13.3.4.      Financial Overview

                              13.3.5.      SWOT Analysis

                              13.3.6.      Key Developments

               13.4.     BRISTOL-MYERS SQUIBB COMPANY

                              13.4.1.      Key Facts

                              13.4.2.      Business Description

                              13.4.3.      Products and Services

                              13.4.4.      Financial Overview

                              13.4.5.      SWOT Analysis

                              13.4.6.      Key Developments

               13.5.     JOHNSON AND JOHNSON SERVICES, INC.

                              13.5.1.      Key Facts

                              13.5.2.      Business Description

                              13.5.3.      Products and Services

                              13.5.4.      Financial Overview

                              13.5.5.      SWOT Analysis

                              13.5.6.      Key Developments

               13.6.     AUROBINDO PHARMA

                              13.6.1.      Key Facts

                              13.6.2.      Business Description

                              13.6.3.      Products and Services

                              13.6.4.      Financial Overview

                              13.6.5.      SWOT Analysis

                              13.6.6.      Key Developments

               13.7.     ABBVIE INC.

                              13.7.1.      Key Facts

                              13.7.2.      Business Description

                              13.7.3.      Products and Services

                              13.7.4.      Financial Overview

                              13.7.5.      SWOT Analysis

                              13.7.6.      Key Developments

               13.8.     GLAXOSMITHKLINE PLC.

                              13.8.1.      Key Facts

                              13.8.2.      Business Description

                              13.8.3.      Products and Services

                              13.8.4.      Financial Overview

                              13.8.5.      SWOT Analysis

                              13.8.6.      Key Developments

               13.9.     F. HOFFMANN-LA ROCHE LTD

                              13.9.1.      Key Facts

                              13.9.2.      Business Description

                              13.9.3.      Products and Services

                              13.9.4.      Financial Overview

                              13.9.5.      SWOT Analysis

                              13.9.6.      Key Developments

               13.10.     GILEAD SCIENCES, INC.

                              13.10.1.      Key Facts

                              13.10.2.      Business Description

                              13.10.3.      Products and Services

                              13.10.4.      Financial Overview

                              13.10.5.      SWOT Analysis

                              13.10.6.      Key Developments

14.        APPENDIX

               14.1.       ABOUT THE INSIGHT PARTNERS

               14.2.       GLOSSARY OF TERMS

The List of Companies
  1. Merck and Co., Inc.
  2. Dr. Reddy’s Laboratories Ltd.
  3. Cipla Inc.
  4. Bristol-Myers Squibb Company
  5. Johnson and Johnson Services, Inc.
  6. Aurobindo Pharma
  7. AbbVie Inc.
  8. GlaxoSmithKline plc.
  9. F. Hoffmann-La Roche Ltd
  10. Gilead Sciences, Inc.
TIPRE00012650
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking